Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2022 / Cilt: 28 - Sayı: 3

Comparison of pre-operative platelet functions by thromboelastogram in patients selective serotonin reuptake inhibitors user and non-user

Pages
276–280
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the evaluation based on duration of SSRI use, there was no statistically significant difference between those whose duration of use was more than 1 year and

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: The use of antidepressant drugs, in particular selective serotonin reuptake inhibitors (SSRIs), has increased in recent years.
📊
Key Findings & Data:METHODS: The study was designed for 60 patients whose physical status was classified according to the American Society of Anes- thesiology (ASA) classification as ASA I–II were included in the study.
💡
Conclusion & Impact:In the evaluation based on duration of SSRI use, there was no statistically significant difference between those whose duration of use was more than 1 year and
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND: The use of antidepressant drugs, in particular selective serotonin reuptake inhibitors (SSRIs), has increased in recent years. Using SSRIs can cause changes in serotonin metabolism. Serotonin provides platelet aggregation and plays a role in the regulation of vascular tone and coagulation processes. The aim of this study was to evaluate the effects of SSRI use on coagulation functions with thromboelastogram (TEG) in patients undergoing surgical operation and to compare with non-user cases. METHODS: The study was designed for 60 patients whose physical status was classified according to the American Society of Anes- thesiology (ASA) classification as ASA I–II were included in the study. During routine pre-operative blood tests, 2 ml complete blood sample used and TEG performed. The cases were divided into two groups as SSRI user and non-user and analyzed. RESULTS: R value was higher in SSRI user patients than in non-user patients. The MA value was significantly lower in SSRI user. There was no statistically significant difference in other parameters. In the evaluation based on duration of SSRI use, there was no statistically significant difference between those whose duration of use was more than 1 year and

🔖

Cite This Article

Yılmaz, R., Yusifov, M., Hacıbeyoglu, G., Arican, S., Topal, A. (2022). Comparison of pre-operative platelet functions by thromboelastogram in patients selective serotonin reuptake inhibitors user and non-user. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 28 - Sayı: 3, 276–280. https://ajindex.com/articles/644034

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bismuth-Evenzal Y, Gonopolsky Y, Gurwitz D, Iancu I, Weizman A, Rehavi M. Decreased serotonin content and reduced agonist-induced ag- gregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord 2012;136:99–103
  2. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: Pop- ulation based cohort study. BMJ 2011;343:d4551
  3. Verdel BM, Souverein PC, Meenks SD, Heerdink ER, Leufkens HG Eg- berts TC. Use of serotonergic drugs and the risk of bleeding. Clin Phar- macol Ther 2011;89:89–96
  4. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12–6
  5. Oyesanmi O, Kunkel EJ, Monti DA, Field HL. Hematologic side effects of psychotropics. Psychosomatics 1999;40:414–21
  6. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dia- logues Clin Neurosci 2007;9:47–59
  7. Aylı M, Şekerci S. Hemostasis problems, transfusion and blood conser- vation techniques in cardiovascular surgery. Turk Klin J Anest Reanim 2008;6:145–8
  8. Demir M, Tekgündüz E. Perioperative hemostatic evaluation: Scientific letter. Turk Klin J Med Sci 2008;28:361–8
  9. Kozek-Langenecker SA. The effects of drugs used in anaesthesia on platelet membrane receptors and on platelet function. Curr Drug Targets 2002;3:247–58
  10. Lake MB, Birmaher B, Wassick S, Mathos K, Yelovich AK. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. J Child Adolesc Psychopharmacol 2000;10:35–8
  11. Mirsal H, Kalyoncu A, Pektaş O. Ecchymosis associated with the use of fluoxetine: Case report. Turk Psikiyatr Derg 2002;13:320–4
  12. Lippi G, Favaloro EJ, Salvagno GL, Franchini M. Laboratory assessment of perioperative management of patients on anitplatelet therapy: From bench to the bedside. Clin Chim Acta 2009;405:8–16
  13. Miller JL, Rao AK. Blood platelets and von Willebrand disease. In: McPherason RA, Pincus MR, editors. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. Philadelphia, PA: El- seiver-Saunders; 2011. p. 801–22
  14. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of de- pression: Focus on the serotonin transporter. Clin Chem 1994;40:288– 95
  15. Hervig TA, Farstad M. Human blood platelet serotonin studied in vitro: Endogenous serotonin may stimulate thrombin-induced serotonin re- lease in stored platelets. Platelets 1996;7: